4D pharma Plc (LBPS), a British company focused on Live Biotherapeutic products or LBPs, said on Monday that it has appointed John Doyle as new Chief Financial Officer or CFO.
Doyle will succeed John Beck, who passed away last year, during his tenure as the finance chief.
The new CFO brings over 15 years of experience leading and developing the financial operations, strategy and investor relations functions at public healthcare companies, the UK-based company said in a statement.
Doyle joins 4D pharma after serving as CFO at Chiasma Inc.,a biopharmaceutical company acquired by Amryt Pharma in 2021. Prior to Chiasma, he worked as Vice President of Finance and Investor Relations at Verastem Inc.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.